Evidence map›Paper›PMID 35122336›Full record

ArticleProteins2022

Structural evolution of the ancient enzyme, dissimilatory sulfite reductase.

Daniel R Colman, Gilles Labesse, Gurla V T Swapna, Johanna Stefanakis, Gaetano T Montelione, Eric S Boyd, Catherine A Royer

Abstract read
In one paragraph

Article in Proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Characterization of DsrD and its interaction with the DsrAB dissimilatory sulfite reductase.Protein science : a publication of the Protein Society · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel R ColmanDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA.ORCID 0000-0002-3253-6833
Gilles LabesseCentre de Biochimie Structurale, CNRS UMR 5048, Montpellier, France.ORCID 0000-0002-6861-3300
Gurla V T SwapnaDepartment of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers The State University of New Jersey, Piscataway, New Jersey, USA.ORCID 0000-0001-9342-2525
Johanna StefanakisThe Bronx High School of Science, New York, New York, USA.
Gaetano T MontelioneDepartment of Chemistry and Chemical Biology, and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.ORCID 0000-0002-9440-3059
Eric S BoydDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA.ORCID 0000-0003-4436-5856
Catherine A RoyerDepartment of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA.ORCID 0000-0002-2670-3391

Funding

Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic MicroorganismsR35GM141818 · NIGMS · RENSSELAER POLYTECHNIC INSTITUTE · PI MONTELIONE, GAETANO T · 2021 to 2025
$3.3M
Membrane Protein Structure Using Evolutionary Couplings and Sparse NMR DataR01GM120574 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI MONTELIONE, GAETANO T · 2017 to 2020
$2.3M
NIGMS NIH HHS R01 GM120574NIGMS NIH HHS R35 GM141818
6 · The paper itself

Abstract

Dissimilatory sulfite reductase is an ancient enzyme that has linked the global sulfur and carbon biogeochemical cycles since at least 3.47 Gya. While much has been learned about the phylogenetic distribution and diversity of DsrAB across environmental gradients, far less is known about the structural changes that occurred to maintain DsrAB function as the enzyme accompanied diversification of sulfate/sulfite reducing organisms (SRO) into new environments. Analyses of available crystal structures of DsrAB from Archaeoglobus fulgidus and Desulfovibrio vulgaris, representing early and late evolving lineages, respectively, show that certain features of DsrAB are structurally conserved, including active siro-heme binding motifs. Whether such structural features are conserved among DsrAB recovered from varied environments, including hot spring environments that host representatives of the earliest evolving SRO lineage (e.g., MV2-Eury), is not known. To begin to overcome these gaps in our understanding of the evolution of DsrAB, structural models from MV2.Eury were generated and evolutionary sequence co-variance analyses were conducted on a curated DsrAB database. Phylogenetically diverse DsrAB harbor many conserved functional residues including those that ligate active siro-heme(s). However, evolutionary co-variance analysis of monomeric DsrAB subunits revealed several False Positive Evolutionary Couplings (FPEC) that correspond to residues that have co-evolved despite being too spatially distant in the monomeric structure to allow for direct contact. One set of FPECs corresponds to residues that form a structural path between the two active siro-heme moieties across the interface between heterodimers, suggesting the potential for allostery or electron transfer within the enzyme complex. Other FPECs correspond to structural loops and gaps that may have been selected to stabilize enzyme function in different environments. These structural bioinformatics results suggest that DsrAB has maintained allosteric communication pathways between subunits as SRO diversified into new environments. The observations outlined here provide a framework for future biochemical and structural analyses of DsrAB to examine potential allosteric control of this enzyme.

Indexed as

Hydrogensulfite ReductaseOxidoreductases Acting on Sulfur Group DonorsHemePhylogenySulfatesHemeHydrogensulfite ReductaseOxidoreductases Acting on Sulfur Group DonorsSulfatesdissimilatory sulfite reductaseevolutionary covariancephylogenystructural modeling

Identifiers

PMID35122336
PMCPMC9018543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.